Javascript must be enabled to continue!
Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils
View through CrossRef
AbstractCytokine‐mediated inhibition of eosinophil apoptosis is a mechanism causing tissue eosinophilia. Previously published work suggested that activation of the Lyn‐Ras‐Raf‐1‐MAP kinase pathway is obligatory for prevention of eosinophil apoptosis by eosinophil hematopoietins. We demonstrate herein that activation of freshly isolated human blood eosinophils by granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is associated with increased tyrosine phosphorylation of Jak2. The tyrosine kinase blocker, tyrphostin B42, prevented activation of Jak2 but not Lyn, suggesting that Jak2 is the specific target for tyrphostin B42 in eosinophils. In addition, since Lyn remained unaffected by tyrphostin B42, it is unlikely that Jak2 is required for Lyn activation in this model. To test whether tyrosine phosphorylation of Jak2 is linked to GM‐CSF‐mediated prolonged eosinophil survival, we determined the effect of tyrphostin B42 on eosinophil viability and apoptosis. Prevention of Jak2 activation by tyrphostin B42 was associated with the inability of GM‐CSF to prevent eosinophil apoptosis. These data suggest that disruption of not only the Lyn‐Ras‐Raf‐1‐MAP kinase but also the Jak‐STAT pathway blocks the ability of eosinophil survival factors to prevent apoptosis in eosinophils.
Title: Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils
Description:
AbstractCytokine‐mediated inhibition of eosinophil apoptosis is a mechanism causing tissue eosinophilia.
Previously published work suggested that activation of the Lyn‐Ras‐Raf‐1‐MAP kinase pathway is obligatory for prevention of eosinophil apoptosis by eosinophil hematopoietins.
We demonstrate herein that activation of freshly isolated human blood eosinophils by granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is associated with increased tyrosine phosphorylation of Jak2.
The tyrosine kinase blocker, tyrphostin B42, prevented activation of Jak2 but not Lyn, suggesting that Jak2 is the specific target for tyrphostin B42 in eosinophils.
In addition, since Lyn remained unaffected by tyrphostin B42, it is unlikely that Jak2 is required for Lyn activation in this model.
To test whether tyrosine phosphorylation of Jak2 is linked to GM‐CSF‐mediated prolonged eosinophil survival, we determined the effect of tyrphostin B42 on eosinophil viability and apoptosis.
Prevention of Jak2 activation by tyrphostin B42 was associated with the inability of GM‐CSF to prevent eosinophil apoptosis.
These data suggest that disruption of not only the Lyn‐Ras‐Raf‐1‐MAP kinase but also the Jak‐STAT pathway blocks the ability of eosinophil survival factors to prevent apoptosis in eosinophils.
Related Results
Ezh2 Loss Accelerates JAK2V617F-Driven Primary Myelofibrosis
Ezh2 Loss Accelerates JAK2V617F-Driven Primary Myelofibrosis
Abstract
Polycomb group proteins are transcriptional repressors that epigenetically regulate transcription via histone modifications. There are two major polycomb-co...
Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction
Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction
AbstractJAK2 activation is crucial for cytokine receptor signal transduction and leukemogenesis. However, the underlying processes that lead to full activation of JAK2 are unclear....
TEL-JAK2 transgenic mice develop T-cell leukemia
TEL-JAK2 transgenic mice develop T-cell leukemia
Abstract
We previously reported a fusion between TEL and JAK2in a t(9;12)(p24;p13) chromosomal translocation in childhood acute T-cell leukemia. This fusion gene enc...
TEL-JAK2 transgenic mice develop T-cell leukemia
TEL-JAK2 transgenic mice develop T-cell leukemia
We previously reported a fusion between TEL and JAK2in a t(9;12)(p24;p13) chromosomal translocation in childhood acute T-cell leukemia. This fusion gene encodes a TEL-JAK2 chimeric...
JAK2 variations and functions in lung adenocarcinoma.
JAK2 variations and functions in lung adenocarcinoma.
e23181 Background: Lung cancer ranks as the first most common cancer and the first leading cause of cancer-related death in China and worldwide. Due to the difficulty in early dia...
Low Incidence of V617FJAK2 Mutation in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Low Incidence of V617FJAK2 Mutation in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Abstract
Background: V617F JAK2 mutation is a typical molecular finding in BCR-ABL-negative myeloproliferative neoplasms (MPN). The same abnormality has also been re...
Role of granulocyte colony stimulating factor (G-CSF) in dengue patients with severe thrombocytopenia
Role of granulocyte colony stimulating factor (G-CSF) in dengue patients with severe thrombocytopenia
Objective: To determine the effects of granulocyte colony-stimulating factor in improving platelet count in patients with dengue fever.
Method: The retrospective, cross-sectional s...
Diagnostic Performance of Red Blood Cell Indices, Serum Erythropoietin, and JAK2 Mutation Testing for the Evaluation of Polycythemia Vera at High Altitude
Diagnostic Performance of Red Blood Cell Indices, Serum Erythropoietin, and JAK2 Mutation Testing for the Evaluation of Polycythemia Vera at High Altitude
Introduction:
Polycythemia vera (PV) is a clonal myeloproliferative neoplasm associated with mutation of Janus kinase 2 ( JAK2) in virtually all patients. Patients w...

